Filing Details

Accession Number:
0001593968-21-002386
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-15 16:48:31
Reporting Period:
2021-11-15
Accepted Time:
2021-11-15 16:48:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553231 J Laurie Olson C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-15 1,000 $84.86 1,000 No 4 M Direct
Common Stock Disposition 2021-11-15 1,000 $138.24 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-11-15 1,000 $0.00 1,000 $84.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2030-08-11 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
  2. This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.